ACHV
Achieve Life Sciences
–
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 30.49M; Volume: 25.36K; AvgVol 3m: 582.11K; Beta: 1.75;
Cost estimate:
P/E: –; EPS: -16.68; EPS growth quarter/prev quarter: 83.40%;
EPS growth this year: 45.00%; EPS growth past 5 years: ;
EPS ttm: -16.68;
P/S: ; P/B: 01.03; P/Cashflow: ; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -79.80%; ROE – return on equity: -94.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 1.13%; Insider Transactions:0.00%;
Institutional Ownership: 15.00%; Institutional Transactions: 116.83%;
Data update: 07.10.2020.